Clovis Reaches $142M Deal To Resolve Stock Drop Suit
Clovis Oncology Inc. has agreed to pay $142 million in cash and stock to settle a proposed class action that claimed the company inflated its stock price by misleading investors about...To view the full article, register now.
Already a subscriber? Click here to view full article